StockVS

Quantum-Si incorporated (QSIAW) Stock Analysis

Quantum-Si incorporated

$0.20

+$0.16 (+455.43%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

Quantum-Si incorporated functions as a life sciences entity dedicated to developing a proprietary, universal, and single-molecule detection platform specifically applied to proteomics to facilitate next-generation protein sequencing. The company operates within the life sciences sector, focusing on advanced instrumentation that provides single-molecule, amino acid level resolution for scientific applications. In terms of scale, the organization employs 145 individuals and reports a trailing twelve-month revenue of $2.44 million, while its market capitalization and price-to-book valuation are recorded at 0.14 relative to book value. The reported revenue figure of $2.44 million combined with the current market dynamics suggests the company operates with a relatively small revenue base, while the specific valuation metrics available indicate a pricing structure that reflects its current financial position rather than established large-cap stability.

Financial Health

The company reported a trailing twelve-month revenue of $2.44 million against a net income of $-101,339,000 and an EBITDA of $-92,594,000, revealing a significant divergence between top-line generation and bottom-line profitability. This substantial gap between revenue and net income highlights an aggressive cost structure or significant non-operating expenses that consume nearly 42 times the reported revenue, resulting in a net loss that far exceeds operational cash generation. Free cash flow stands at $-45,797,000, indicating that the company is currently burning cash rather than generating liquidity, which limits its immediate financial flexibility for capital expenditures or acquisitions without external financing. Profitability is further constrained by a gross margin of 47.3%, an operating margin of -4677.2%, and a profit margin of 0.0%, where the negative operating margin suggests that operational costs are disproportionately high relative to revenue, effectively erasing all gross profit before reaching the net loss. Despite the losses, the balance sheet holds $162.91 million in cash against $4.17 million in debt, supported by a debt-to-equity ratio of 1.89. The current ratio of 7.64 indicates a robust short-term liquidity position, suggesting the company can comfortably meet its short-term obligations with its existing liquid assets. Return on Equity is reported at -46.5% and Return on Assets at -24.6%, metrics that reveal the company is currently destroying shareholder and asset value, indicating that management is not generating sufficient returns on the capital deployed to date.

Valuation Assessment

Valuation metrics for Quantum-Si incorporated include a P/E Ratio (TTM) and Forward P/E both listed as N/A, meaning traditional earnings-based valuation models cannot be applied due to the absence of positive earnings. The price-to-book ratio is 0.14, which indicates that the market is valuing the company at a fraction of its book value, suggesting a deep discount or a market perception that the asset base is impaired or that future earnings potential is highly uncertain. Alternative valuation metrics such as the price-to-sales ratio and EV/EBITDA are also N/A, reinforcing that the company does not currently generate the positive earnings or cash flow required for standard comparative valuation analysis. The stock has a 52-week high of $0.14 and a 52-week low of $0.14, meaning the current trading price is effectively trading at 0% deviation from the 52-week high and low, indicating a lack of price discovery or significant intrayear volatility in terms of range. The beta value is 3.08, which signifies that the stock price is expected to be highly volatile, moving approximately three times as much as the broader market index in either direction, thereby exposing investors to amplified price swings relative to general market movements.

Growth & Income

Revenue growth over the past year is -62.2%, while earnings growth is N/A, indicating a sharp contraction in top-line sales and the absence of positive earnings growth to compare against revenue changes. The negative revenue growth suggests that the company is facing significant headwinds in its market, as it is unable to expand sales or even maintain its current revenue levels, while the lack of earnings growth data further complicates the assessment of operational efficiency improvements. As the company does not pay a dividend, indicated by a dividend yield of N/A and a payout ratio of N/A, it does not distribute any portion of its earnings to shareholders, instead retaining all capital to attempt to fund operations and research. The overall growth and income profile for Quantum-Si incorporated is characterized by a sharp decline in revenue, a complete absence of dividend income, and a reliance on existing cash reserves to sustain operations during this period of negative growth and profitability.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Quantum-Si incorporated

Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It also provides Platinum analysis software, a cloud-based solution that automates data analysis workflows and visualizes the sequencing results. The company was founded in 2013 and is headquartered in Branford, Connecticut.

Visit website →

Key Statistics

Market Cap
N/A
P/E Ratio
N/A
52-Week High
$0.04
52-Week Low
$0.04
Beta
3.16

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NASDAQ
Country
United States
Employees
145